Trump Signs HK Bill, China Vows to Retaliate. What's Next? Trump Signs HK Bill, China Vows to Retaliate. What's Next? Trump Signs HK Bill, China Vows to Retaliate. What's Next?

Trump Signs HK Bill, China Vows to Retaliate. What's Next?

Equities 4 minutes to read

Summary:  US President Donald Trump has signed the Hong Kong Human Rights and Democracy Act of 2019 into law. He also signed another bill banning the sale of ammunitions including tear gas and rubber bullets to Hong Kong police. A move that is sure to complicate ongoing trade negotiations and anger Chinese officials against the backdrop of an already fraught relationship between the US and China.


US President Donald Trump has signed the Hong Kong Human Rights and Democracy Act of 2019 into law. He also signed another bill banning the sale of ammunitions including tear gas and rubber bullets to Hong Kong police. A move that is sure to complicate ongoing trade negotiations and anger Chinese officials against the backdrop of an already fraught relationship between the US and China.

The bill, though largely symbolic in nature and somewhat toothless, stipulates annual reviews of Hong Kong’s special trade status and sanctions officials engaged in human rights abuses. But the problem is that for Beijing, this bill is viewed as interfering with internal affairs and they have previously threated to retaliate should the bill be signed.

This threat has again been reiterated today but lacked details of retaliatory proceedings with China saying the move to sign the bill violates international laws and aims to damage the practice of "one country, two systems,". A representative from the Ministry of Foreign Affairs tweeting, “US is a complete bully. Holding high the banner of "America first", it is only thinking about taking advantage of others. It raises tariffs whenever it likes. It abuses the monopoly status of US dollar while imposing unilateral sanctions & long-arm jurisdiction at every turn.”

As the news that Trump had signed the bill into effect broke this morning US futures and Asian indices exhibited a sharp risk off move, the yuan slid and yen, gold and treasuries were bid, despite US stocks making fresh record highs overnight. Despite China’s vows to retaliate the yuan fix, a key barometer of tensions between the two sides, was in line with estimates and raised by 78 pips relative to yesterday’s fix. Perhaps signalling that Beijing’s bark may be worse than their bite on this occasion.

Although there is no doubt this move will aggravate Beijing, congress essentially had a veto-proof majority and Trump had little choice but to sign the bill as it passed through the House on a 417-1 majority. The landslide win for pro-democracy candidates in Hong Kong earlier this week should also help US trade negotiators persuade Beijing that the bill shouldn’t derail ongoing negotiations as Trump’s hands were tied and that Hong Kong should be a separate issue to the interim deal. But as always this is further evidence that a partial/interim deal will only provide temporary relief from long-term bilateral tensions.

If US trade negotiators can persuade Beijing that the bill shouldn’t derail ongoing negotiations, although a bitter cup to drink, delaying the December 15th tariff hike could soften the blow for China. But given the recent rally in risk assets markets have priced in a great deal of hope and optimism around trade with equity markets largely priced for a phase one deal to be signed. This added uncertainty will see some of that complacency unwind somewhat, particularly given the shortened Thanksgiving trading week which likely sees traders eager to lock in some profits and wait to see how the story develops.

The key risk being that if China does retaliate and tie the Hong Kong bill to the partial trade deal, liquidity is thin given the shorter trading week, the VIX is compressed, a lot of optimism is priced, and valuations are stretched as equities have been fuelled by trade hope and multiple expansion not economic realities. Meaning a ratcheting higher in tensions could see some sharp downwards moves. Any Q4 2018 style meltdown would likely be avoided as we are dealing with a different Fed, rate hikes are no longer on the table and they have already kowtowed to the markets demands for liquidity. Not just the Fed, but globally central bankers have taken an accommodative stance. In Australia the RBA have delivered three rate cuts to date and we expect further easing will be delivered.

Given both the US and Chinese economies are now more visibly slowing than when talks broke down previously, there seems to be impetus on either side to close a partial deal so our base is that the signing of the Hong Kong bill will not derail negotiations. There is enough low hanging fruit to put together a watered-down deal, despite our long-held notion the two sides remain far apart on fundamental issues. We still maintain that China will concede little that is not within their own self-interest and the broad reaching core issues will remain unaddressed. However, an olive branch from Trump that defers the December 15th tariffs and a few more tweets about how imminent a deal is, likely sees dip buyers step in and risk off moves reversed.

Medium term we still maintain that growth continues to be buffeted by both cyclical and geopolitical headwinds, despite nascent signs of stabilisation. But this is not currently driving the tape action in markets. Improving sentiment has largely been propelled by “less bad news” and the Feds liquidity injections, but incoming data shows the synchronised global slowdown has persisted into Q4 and leading indicators are still deteriorating. OECD leading indicators remain weak across the globe highlighting that the recent stabilisation across manufacturing PMIs could be a false flag and it is too early to sound the all clear. When we cut through the headlines, it is clear the global economy continues to slow but the downdraft may be stabilising, so now is the time to be avidly data dependant. Whilst also remembering, a trade deal will not save late cycle dynamics from materialising. For the global economy to truly benefit from the any trade deal there needs to be a revival in animal spirits that reignite capex and manufacturing, thus arresting the bleed into the services sector where the bulk of employment sits. For that to happen there must be a comprehensive deal that covers a roll back of tariffs, removes uncertainty and reignites business confidence.

Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.